| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.06 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.06 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.35 | 0.07 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.056 | 0.07 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.07 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.07 |